FDA Adds J&J Vaccine Warning to ‘Serious But Victim’ Autoimmune Disorder • Protecting Children’s Health

The U.S. Food and Drug Administration will announce a new warning about Johnson & Johnson’s COVID vaccine that says the shooting is linked to Guillain-Barré syndrome. In April, the agency added a warning about blood -borne diseases in the J&J shooting.

Defender experienced censorship on many social channels. Be sure to keep in touch with news that matters subscribe to our top news of the day. It’s free.

The U.S. Food and Drug Administration (FDA) is issue a new Johnson & Johnson (J&J) COVID vaccine warning says shooting is linked to Guillain-Barré syndrome (GBS), a “severe but rare” autoimmune disorder. The Washington Post reported the news on “four individuals familiar with the situation.”

Agreed to The New York Times, the chance of developing GBS after receiving a J&J shot is three to five times higher than expected by the majority of the U.S. population

About 100 introductory reports in the U.S. GBS was detected after receiving J&J vaccine, the Centers for Disease Control and Prevention (CDC) said in a statement on CNN now Most cases are reported about two weeks after vaccination, most in men 50 and older.

The CDC’s Advisory Committee on Immunization Practices (ACIP) is expected to discuss GBS cases at an upcoming meeting, according to the CDC.

GBS is a rare neurological disease where the body’s immune system mistakenly attacks part of its peripheral nerve system – the network of nerves that lie outside the brain and spinal cord – and can go from a mild case with brief weakness to paralysis , leaving the person unable to breathe independently.

While the cause of GBS is not fully known, it often follows infection with a virus and has already become associated with other vaccines.

the The FDA is over the benefits of the vaccine outweigh any risks, but will include the provision of actual medication sheets for patient providers.

“It’s not surprising to find these classes in bad events with vaccination, ”said Dr. Luciana Borio, former acting chief scientist of the FDA. Data collected so far by the FDA, according to Borio, suggests that the benefits of the vaccine “continue to outweigh the risks.”

GBS reports are rare, the CDC says, “But likely indicates a small potential risk of this effect following” on J&J vaccine.

Federal officials recognized the 100 suspected cases of GBS among J&J recipients shot through the CDC’s Vaccine Adverse Events Reporting System (VAERS) – a federal monitoring system that relies on patients and health care providers to report adverse effects of vaccines.

Agreed to latest data from VAERS, between December 14, 2020 and July 2, there were 398 reports of GBS with 187 cases dedicated Pfizer, 159 to Moderna and 76 cases in J&J.

No link found between GBS vaccine and mRNA COVID developed by Pfizer-BioNTech or Modern even in VAERS reports.

VAERS data show the onset of GBS symptoms after J&J vaccination within about three weeks of vaccination, The New York Times reports. One recipient, a 57-year-old man from Delaware who has suffered both a heart attack and stroke in the last four years, died the first of April after he was vaccinated and developed GBS.

As in The Defender reports July 8, a third-grade teacher developed GBS three weeks after being received J & J’s Covid vaccine. Stacie [last name unknown] several times going to the emergency room after being shot because he experienced numbness in the lower extremities, but was sent home without confirming the tests.

The numbness continued to progress and eventually Stacie lost her ability to stand and walk. He was hospitalized and diagnosed with GBS.

Gary Spaulding an active landscaper who experienced a severe headache after receiving J & J’s COVID vaccine, causing him to go to the emergency room. Doctors immediately diagnosed Spaulding with Lyme Disease. Treatment was started, but numbness and tingling in his upper part improved. After doctors started tests to determine the cause of the growing series of symptoms, it was diagnosed with SpaSubing with GBS.

Doctors believe that Spaulding’s immune system, which fights Lyme Disease, was overdosed on the COVID vaccine causing the attack. myelin – the protective separation that surrounds the nerves, including those in the brain and spinal cord.

Treatment was quick and successful to catch the progression of the disease, but Spaulding was not yet nearly paralyzed.

In April, Defender reports in a Texas teenager who was diagnosed with GBS a few weeks after his first dose of COVID-19 vaccine. The teen said he believed the vaccine was to blame, according to a local report by KPRC2 on the Houston news channel.

“I want to get the vaccine,” said Wyatt McGlaun, a senior high school from The Woodlands. “I feel like this is the right thing to do. I wanted to travel and enjoy my last summer before college. ”

A few weeks after receiving the vaccine, McGlaun was exhausted and had difficulty walking. He was admitted to health at CHI St. Luke where he was diagnosed with GBS. News reports did not disclose what vaccine the teen received.

J&J is associated with blood clotting diseases

This is the second time J&J’s COVID vaccine has been linked to a severe adverse reaction. On April 13, federal officials temporarily halted J&J shooting after health officials confirmed they were investigating six U.S. blood cases

During the April 23 meeting, ACIP said it had already found out 15 women was diagnosed with abnormal blood clots, including three who died. Only two of the women were older than 50, with the most at-risk women aged 30 to 39.

The CDC’s safety advisory committee says the relationship between blood pressure and COVID vaccine at J&J is “credible,” but concludes the vaccine’s benefits outweigh the risks and recommends the vaccine for those. people aged 18 and over in the United States under the FDA Emergency Use Permit (USA).

On April 26, the The FDA has revised it it is EUA for the J&J vaccine to show the risk of rare blood clots and to say that vaccination can continue immediately.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *